Soluble suppression of tumorigenicity 2 (sST2) is known as a strong risk predictor in patients with heart failure (HF) and provides additional prognostic value to NT-proBNP. The purpose of this… Click to show full abstract
Soluble suppression of tumorigenicity 2 (sST2) is known as a strong risk predictor in patients with heart failure (HF) and provides additional prognostic value to NT-proBNP. The purpose of this study is to investigate the value of sST2 in Atrial fibrillation (AF) patients. We enrolled 596 patients
               
Click one of the above tabs to view related content.